Squid Game: Direct Drug Delivery Into GI Tract Using Cephalopod-Inspired Capsules Researchers at Massachusetts Institute of Technology and Novo Nordisk designed capsules to deliver the drugs without needles, instead using jet propulsion, drawing inspiration from nature, specifically cephalopods like squids, which are known for their ink ejection abilities.
Genetic Engineering & Biotechnology News
图书期刊出版业
New Rochelle，New York 180,050 位关注者
The Bedrock of Biotech
关于我们
Genetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc. Celebrating its 40th anniversary in 2021, GEN was the first publication in this field and remains the key driver in the explosion of the industry, paving the way for the development of new tools and technologies, investment growth, and career opportunities. Through its cornerstone Magazine, dynamic Website, high-frequency eNewsletters, and innovative suite of multimedia, GEN is the 360-degree resource that researchers and executives depend on for information that is pivotal for their success. GEN’s breadth of editorial coverage is unrivaled, providing exclusive reporting, insight, and analysis across the life sciences – from its five foundational pillars of Drug Discovery, Bioprocessing, OMICS, Translational Medicine, and Gene Editing to a new, expanded focus on the emerging areas of Cancer Research, Infectious Diseases, and Artificial Intelligence. Within these areas, GEN delivers exclusive, high-quality reporting on the latest industry news; insider information on cutting-edge tools and technologies; industry-standard protocols, tutorials, and technical articles; first-looks at emerging industry collaborations and investments; reports from key scientific and industry meetings; and A-Lists, our monthly insight and analysis into the top companies, products, and movers & shakers impacting the industry today.
- 网站
-
https://www.genengnews.com
Genetic Engineering & Biotechnology News的外部链接
- 所属行业
- 图书期刊出版业
- 规模
- 51-200 人
- 总部
- New Rochelle，New York
- 类型
- 私人持股
- 创立
- 1981
- 领域
- Biotechnology、Drug Discovery、Bioprocessing、Translational Medicine、OMICS和Genome Editing
地点
-
主要
获取路线
140 Huguenot St
US，New York，New Rochelle，10801
Genetic Engineering & Biotechnology News员工
动态
-
LAST CHANCE! Imaging Large Multiprotein Complexes Using Native Nano-DESI Mass Spectrometry In this GEN webinar TODAY, Dr. Helen Cooper, a leading analytic alchemist from the University of Birmingham, U.K., will discuss improvements in mass spectrometry imaging technology that enable the characterization of the precise protein forms present in multiprotein complexes. Register now to join us for this free webinar sponsored by Thermo Fisher Scientific: https://hubs.li/Q02Yd7VS0 #Omics
-
-
Lonza Completes First GMP Batch at Next-Generation Mammalian Manufacturing Facility The new facility also complements the existing commercial mammalian-derived product manufacturing at 6,000L and 20,000L scales provided from Portsmouth, NH.
Lonza Completes First GMP Batch at Next-Generation Mammalian Manufacturing Facility
genengnews.com
-
World Health Organization (WHO) World Antimicrobial Resistance (AMR) Awareness Week - bringing attention to the urgent need for new antibacterial drugs In a new study reports that researchers have demonstrated that a modified darobactin—a compound derived originally from a bacterium—is a potential antibacterial treatment. The team reports proof-of-concept animal trials on infections caused by bacteria that are known to develop drug resistance.
Antibiotic Compound, Darobactin, Shows Potency in Multiple Models
genengnews.com
-
Human Antibody Discovery May Point to Vaccines Protecting Against Severe Malaria Researchers at EMBL Barcelona, The University of Texas at San Antonio, K?benhavns Universitet - University of Copenhagen, University of California, San Francisco, Fred Hutch, and the Scripps Research have identified two broadly reactive human monoclonal antibodies (mAbs) that can recognize and target some of the proteins that cause severe malaria. The study results could point to future vaccines, and treatment strategies.
Human Antibody Discovery May Point to Vaccines Protecting Against Severe Malaria
genengnews.com
-
NGS Sample Preparation Taking the Pain Out of Painstaking GEN spoke with Betsy Young, PhD, from New England Biolabs, Cande Rogert, PhD, from Illumina, Andrew Gane from Cytiva, and Udayan Umapathi from Volta Labs, Inc. about how the NGS industry is responding to the need for NGS users to enhance productivity while maintaining economy. Here we discussed new strategies promise to streamline workflows, conserve consumables, increase productivity, and enhance reproducibility. Read more https://hubs.li/Q02Z28x00 Don't miss out on the rest of the November issue of GEN https://hubs.li/Q02Z28w80
-
-
Trans-Atlantic Triumph: AI Drug Pioneers Recursion, Exscientia Combine The company vows first- and best-in-class drug discovery based on artificial intelligence after joining forces to create a pipeline of 30+ programs.
Trans-Atlantic Triumph: AI Drug Pioneers Recursion, Exscientia Combine
-
Cmbio Launches to Provide a Centralized Hub for Microbiome and Metabolomics Services The new business combines Clinical Microbiomics, CosmosID, MS-Omics, DNASense, and Microba Life Sciences. The combined company has a team of over 100 experts in microbiome and metabolome science and will provide GxP lab services, advanced bioinformatics, and multiomics solutions that support research in human, animal, and planetary health.
Cmbio Launches to Provide a Centralized Hub for Microbiome and Metabolomics Services
genengnews.com
-
Spatial and Single-Cell Data Combined to Create Comprehensive Cell Map of the Human Gut Mapping these cells can provide further insights into what happens in conditions such as bowel #cancer and IBD. Using this atlas, the Wellcome Sanger Institute researchers and collaborators uncovered a new role of a specific gut cell, highlighting its contributions to a cycle of inflammation in some individuals, possibly causing pain and distress.
Spatial and Single-Cell Data Combined to Create Comprehensive Cell Map of the Human Gut
-
NEW WEBINAR! Is Biopharma Ready for AI? Exploring Tech Strategies Across Large and Small Biopharma Wednesday, December 4, 2024 8:00 am PT, 11:00 am ET, 17:00 CET In this GEN webinar, experts from AbbVie (Mohit Agnihotri) and Benchling (Lauren DeVos) will share insights into the current tech landscape, AI readiness, and the strategies for digital transformation shaping large and small biopharma. Register now to join us for this free webinar sponsored by Benchling: https://hubs.li/Q02YYhFL0 #AI #DrugDiscovery
-